Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Process-for-measuring-the-plasminogen-content-of-a-sample

 Antibody-drug conjugates
OF THE INVENTION The present invention pertains to novel immunoconjugates, intermediates thereto, ...


 Monoclonal antibodies against metal chelates
We claim: 1. A monoclonal antibody which exhibits specificity for a complex comprising a chelating ...


 Preparation of cyclic carbonates using alkylammonium and tertiary amine catalysts
OF THE INVENTION According to the process of the invention, cyclic carbonates having five or six-...


 Thrombin inhibitory new dihydroxybenzene ether derivatives
We claim: 1. An ether derivative of a dihydroxybenzene of the formula ##STR40## wherein the ether ...


 Deer repellent device and method
What is claimed is: 1. A deer repellent assembly comprising: a 100 foot length of one-quarter inch ...


 Solid consumer product compositions containing small particle clyclodextrin complexes
What is claimed is: 1. Pharmaceutical composition comprising an effective amount of active/...


 Water-dispersible protein/polyurethane reaction product
OF THE INVENTION In the process of our invention the isocyanate-capped liquid polyurethane ...


 Polyurethane hydrogels having enhanced wetting rates
What we claim is: 1. A method of improving the wetting rate of a water swellable, lightly ...


 Solid, water-dispersible plastics precursors containing isocyanate groups, a process for the production of aqueous plastics dispersions using such plastics precursors
OF THE INVENTION The plastics precursors according to the present invention are produced by the ...


 Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
OF THE PREFERRED EMBODIMENT In describing the preferred embodiment, certain terminology will be ...


 Process for measuring the plasminogen content of a sample

Details
Inventors: Jacobi, Eckart;
Assignee: Behring-Werke AG. (Marburg, DT)
Primary Examiner: Monacell; A. Louis
Assistant Examiner: Fan; C. A.
Attorney, Agent or Firm: Fraser; Malcolm W.

The plasminogen content of a blood sample is measured by determining the rate of formation of fibrin in a sample in which antiplasmin-free plasminogen is activated to form plasmin before the onset of fibrin formation so that the plasmin-conditioned break-down of the fibrin occurs simultaneously with formation of fibrin.

DETAILED DESCRIPTION What I claim is: 1.
The process of measuring the plasminogen content of a plasma sample comprising the steps of: a.
eliminating any antiplasmin from the plasma sample, b.
adding a predetermined amount of fibrinogen to the sample, c.
adding an amount of plasminogen activator sufficient to activate all possible plasminogen present in the sample, and d.
incubating the sample a sufficient period of time to form a solution of fibrinogen and antiplasmin-free, plasminogen-activated plasma, e.
adding thrombin to the solution, and f.
timing the reaction until the moment of fibrin coagulation is observed in the solution, the plasminogen content to be established by comparing the observed time to fibrin coagulation with an established normal standard.
2.
The process of measuring the plasminogen content of a plasma sample comprising the steps of: a.
eliminating any antiplasmin from the plasma sample, b.
adding a predetermined amount of fibrinogen to the sample, c.
selecting a plasminogen activator from the group consisting of urokinase and streptokinase, d.
adding an amount of the selected plasminogen activator sufficient to activate all possible plasminogen present in the sample, e.
incubating the sample a sufficient period of time to form a solution of fibrinogen and antiplasmin-free, plasminogen-activated plasma, f.
adding thrombin to the solution, and g.
timing the reaction until the moment of fibrin coagulation is observed in the solution, the plasminogen content to be established by comparing the observed time to fibrin coagulation with an established normal standard.
3.
The process of claim 2 wherein the antiplasmins are removed from the plasma sample in step (a.
) by washing the sample with isoamylalcohol.
4.
The process of claim 2 wherein the plasminogen activator used in step (c.
) is urokinase.
5.
The process of claim 2 wherein the plasminogen activator used in step (c.
) is streptokinase.
6.
The process of claim 5 wherein the streptokinase is added to the fibrinogen of step (b



Related patents
  Method for producing thrombolytic preparation
What is claimed is: 1. In a method for producing a thrombolytic preparation from a fresh urine or a crude urokinase solution which consists essentially of (1) adsorbing ...
  Anti-Sm hybridoma
What is claimed is: 1. A continuous cell line which produces anti-Sm antibodies of the IgG class in vitro in hypoxanthine-aminopterin-thymidine medium and comprises a ...
  Aqueous concentrates of salts of .alpha.-sulfonated fatty acid alkyl esters
What is claimed is: 1. An aqueous paste which can be readily pumped at a temperature of about 60.degree. C. or higher consisting essentially of water and an alkali metal ...
  Process for the production of organic fuel
The exact nature of the cellulosic starting material used in the process of this invention is not critical. Virtually any organic material containing cellulose or ...
  Process for the fermentative production of acetone, butanol and ethanol
We claim: 1. The improved process for the production of butanol, acetone and ethanol, by the fermentation of an asporogenic microorganism capable of producing butanol, ...
  Mutant strain of C. acetobutylicum and process for making butanol
We claim: 1. A method of producing butanol which comprises anaerobically culturing a biologically pure culture of Clostridium acetobutylicum ATCC 55025 in a nutrient ...
  Azido-silane compositions
What is claimed is: 1. A solubilized azido-containing silane composition of matter produced by a process which comprises reacting in the presence of a non-aqueous ...
  Substituted triazino-benzimidazoles
What we claim is: 1. A triazinobenzimidazole of the formula ##STR36## wherein R.sub.1 is straight-chain or branched alkyl having 1 to 18 carbon atoms; straight-chain or ...
  Class of bifunctional additives for bioremediation of hydrocarbon contaminated soils and water
What is claimed is: 1. A method for enhancing microbial degradation of hydrocarbon containing water or soil comprising: contacting the hydrocarbon containing soil or ...
  Process for the preparation of halogenomethylketones, in particular of 1,1,1-trifluoroacetone
What is claimes is: 1. Process for the preparation of halogenomethylketones of the formula (I) ##STR4## in which X represents halogen, n represents 1, 2 or 3 and R ...

0.074

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved